Improve Quality Of Life With ibSium®
We’re thrilled to announce that Gnosis by Lesaffre has received the 2024 WholeFoods Magazine Natural Choice Award in the Digestive Health category for our innovative probiotic yeast, ibSium®!
Developed by Gnosis, ibSium® is a patented probiotic yeast registered as Saccharomyces cerevisiae CNCM I-3856. Recognized as a reference probiotic strain, ibSium® has demonstrated its effectiveness in several rigorous clinical studies, showing that this yeast can significantly relieve gastrointestinal symptoms and improve overall quality of life.
Moreover, a recent independent meta-analysis by renowned gastroenterologists further highlights ibSium® as the only probiotic strain significantly reducing abdominal pain.
During SSW, we had great interest in this innovative probiotic yeast for its robust scientific support and its unique advantages as a yeast. Saccharomyces cerevisiae CNCM I-3856 has anti-pathogenic effects in the gut without permanently colonizing the microbiome. Additionally, this natural yeast is compatible with antibiotic treatments, offering a safe and versatile option for digestive support.
We also won an award for MenaQ7® Matrix in the joint health category.
MenaQ7® Matrix, our proprietary Vitamin K2 solution, earned top recognition for supporting cardiovascular and bone health. This advanced technology empowers manufacturers to create complex, innovative formulations, opening new opportunities for using vitamin K2 in supplements.
We are proud to drive advancements in health and wellness with science-based, impactful solutions!
Deep Dive Into K2
Significant research shows vitamin K2 from natural fermentation – especially its key long chain isomers MK-7 – to be essential for bone and cardiovascular-health support.
